Prévention de la «iatrogénie médicamenteuse»

Uložené v:
Podrobná bibliografia
Názov: Prévention de la «iatrogénie médicamenteuse»
Autori: Scheen, André
Informácie o vydavateľovi: 2024.
Rok vydania: 2024
Predmety: Adverse event, Drug interaction, Prevention, Pharmacie, pharmacologie & toxicologie, Sciences de la santé humaine, Pharmacotherapy, Drug-Related Side Effects and Adverse Reactions/prevention & control, Elderly, Risk Factors, Medication Errors/prevention & control, Polypharmacy, Humans, Drug Interactions, Iatrogenic Disease/prevention & control, Human health sciences, Pharmacy, pharmacology & toxicology
Popis: Adverse events related to drug therapy are a major cause of iatrogenicity. They are responsible of increased morbidity, leading to hospitalization, sometimes in emergency, and mortality, not only in ambulatory care but also during hospitalization itself. Causes are multiple : among them, confusion leading to an erroneous drug administration, mistakes regarding dosage, risks associated to self-medication, drug-drug interactions or even food-drug interactions. Elderly population is exposed to an increased incidence of drug iatrogenicity because older patients cumulate numerous risk factors, especially polypharmacy and cognitive disorders. Prevention of drug iatrogenicity is a key objective from a public health point of view. Preventive measures should target the prescriber (physician), the dispenser (pharmacist), the user (patient) and the supplier (pharmaceutical industry).
Druh dokumentu: Article
Jazyk: French
Prístupová URL adresa: https://hdl.handle.net/2268/322514
Prístupové číslo: edsair.od......1318..2d82185f1d1b096ab8ae80fea7d35a10
Databáza: OpenAIRE
Popis
Abstrakt:Adverse events related to drug therapy are a major cause of iatrogenicity. They are responsible of increased morbidity, leading to hospitalization, sometimes in emergency, and mortality, not only in ambulatory care but also during hospitalization itself. Causes are multiple : among them, confusion leading to an erroneous drug administration, mistakes regarding dosage, risks associated to self-medication, drug-drug interactions or even food-drug interactions. Elderly population is exposed to an increased incidence of drug iatrogenicity because older patients cumulate numerous risk factors, especially polypharmacy and cognitive disorders. Prevention of drug iatrogenicity is a key objective from a public health point of view. Preventive measures should target the prescriber (physician), the dispenser (pharmacist), the user (patient) and the supplier (pharmaceutical industry).